NCT01294969已完成4 期
Patient Perception Study for AL-4943A
适应症
干预措施
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 入组人数
- 47
- 试验地点
- 1
- 主要终点
- Overall Patient satisfaction
研究概览
简要总结
To evaluate patient perceptions of Al-4943 in subjects with allergic conjunctivitis previously treated with a topical ocular anti-allergy leukotriene-release inhibitor medication.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 12 Years 至 —（Child, Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •History of allergic conjunctivitis within last 24 months
- •Active signs and symptoms of ocular allergies
排除标准
- •Severe or serious ocular condition, ocular surgical intervention, ocular infection
研究组 & 干预措施
AL-4943A
Experimental
One drop per day in both eyes
干预措施: AL-4943A (Drug)
结局指标
主要结局
Overall Patient satisfaction
时间窗: 7 days
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
已完成
3 期
Efficacy and Safety of an Ophthalmic Solution in Patients With Allergic ConjunctivitisAllergic ConjunctivitisNCT01743027Alcon Research902
已完成
2 期
AL-38583 Ophthalmic Solution for Allergic Conjunctivitis Associated InflammationAllergic ConjunctivitisNCT01001091Alcon Research312
Unknown
4 期
Ocular Allergy Treatment Practical Impact TrialAllergic ConjunctivitisRhinoconjunctivitisNCT01808768Starx Research Center, LLC50
已完成
3 期
Efficacy and Safety of AL-4943A Ophthalmic Solution in Patients With Allergic Conjunctivitis Using the Conjunctival Allergen Challenge (CAC) ModelAllergic ConjunctivitisNCT01479374Alcon Research397
已完成
4 期
Assessment of Alcon's Ocular Image Quantification SystemAllergic ConjunctivitisNCT01282138Alcon Research13